Stocks and Investing
by (remove) : Tim Evans
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Tim Evans
RSSJSONXMLCSV

Tim Evans Maintained (BIO) at Buy with Decreased Target to $280 on, Feb 28th, 2018


Published on 2024-10-26 03:23:19 - WOPRAI, Tim Evans
  Print publication without navigation


Tim Evans of Wells Fargo, Maintained "Bio-Rad Laboratories, Inc." (BIO) at Buy with Decreased Target from $290 to $280 on, Feb 28th, 2018.

Tim, nor any peers, have made any analyst calls on BIO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources